SAN FRANCISCO, June 19, 2018 /PRNewswire/ --
The global pharmaceutical glass packaging market size is expected to reach USD 22.05 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 6.3% during the forecast period. Spiraling sale of generic drugs in developed as well as developing economies is projected to drive the demand for pharmaceutical glass packaging. Glass has a well-defined supply chain in the pharmaceutical industry and is traditionally used for parenteral drug packaging. Extensive R&D is being conducted by product manufacturers in order to minimize negative aspects of glass, such as high susceptibility to breaking and delamination, as well as to improve the quality & efficacy of the product.
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
The pharmerging market is anticipated to witness phenomenal growth owing to favorable government policies and increased healthcare awareness. Governments of developing nations are expanding their public or private healthcare coverage and simultaneously making efforts to minimize out-of-pocket medical expenses for the consumers. Increasing government efforts to reduce healthcare cost and promotion of low-cost generic drugs are estimated to fuel the utilization of glass packaging over the coming years.
Emergence of novel drugs such as cancer drugs and bio-therapeutics is likely to help the market gain traction over the coming years. In an effort to safeguard patient health, guidelines for packaging of biological drugs have been made highly stringent, which necessitates constant development in the field of pharmaceutical packaging. Aforementioned factors promote manufacturers to adopt advanced techniques, thereby driving the market.
In primary pharmaceutical packaging, glass has an advantage over plastic as plastic production requires raw materials such as polyethylene, polypropylene, and polystyrene, which are largely dependent on fluctuating petroleum industry. Manufacturers use soda lime, quartz, and other additives for manufacturing glass. These raw materials are easily available in the market by numerous suppliers. Recent developments in the pharmaceutical glass packaging include launch of Gx Baked-On RTF and an Omniflex plunger, a prefilled syringe, by Gerresheimer AG in September 2017. This technology has the ability to minimize particle loads and meet strict requirements for therapeutic protein products for better deliver of drug.
Browse full research report with TOC on "Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Product (Vials, Ampoules, Cartridges & Syringes), By Drug Type (Generic, Branded, Biologic), And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/pharmaceutical-glass-packaging-market
Further Key Findings From the Report Suggest:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
Web: https://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
Advertisement
The global pharmaceutical glass packaging market size is expected to reach USD 22.05 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 6.3% during the forecast period. Spiraling sale of generic drugs in developed as well as developing economies is projected to drive the demand for pharmaceutical glass packaging. Glass has a well-defined supply chain in the pharmaceutical industry and is traditionally used for parenteral drug packaging. Extensive R&D is being conducted by product manufacturers in order to minimize negative aspects of glass, such as high susceptibility to breaking and delamination, as well as to improve the quality & efficacy of the product.
Advertisement
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
The pharmerging market is anticipated to witness phenomenal growth owing to favorable government policies and increased healthcare awareness. Governments of developing nations are expanding their public or private healthcare coverage and simultaneously making efforts to minimize out-of-pocket medical expenses for the consumers. Increasing government efforts to reduce healthcare cost and promotion of low-cost generic drugs are estimated to fuel the utilization of glass packaging over the coming years.
Emergence of novel drugs such as cancer drugs and bio-therapeutics is likely to help the market gain traction over the coming years. In an effort to safeguard patient health, guidelines for packaging of biological drugs have been made highly stringent, which necessitates constant development in the field of pharmaceutical packaging. Aforementioned factors promote manufacturers to adopt advanced techniques, thereby driving the market.
In primary pharmaceutical packaging, glass has an advantage over plastic as plastic production requires raw materials such as polyethylene, polypropylene, and polystyrene, which are largely dependent on fluctuating petroleum industry. Manufacturers use soda lime, quartz, and other additives for manufacturing glass. These raw materials are easily available in the market by numerous suppliers. Recent developments in the pharmaceutical glass packaging include launch of Gx Baked-On RTF and an Omniflex plunger, a prefilled syringe, by Gerresheimer AG in September 2017. This technology has the ability to minimize particle loads and meet strict requirements for therapeutic protein products for better deliver of drug.
Browse full research report with TOC on "Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Product (Vials, Ampoules, Cartridges & Syringes), By Drug Type (Generic, Branded, Biologic), And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/pharmaceutical-glass-packaging-market
Further Key Findings From the Report Suggest:
- The vials segment is projected to ascend at a CAGR of 6.9% in terms of revenue over the forecast period
- The bottles segment dominated the global pharmaceutical glass packaging market in 2016 in terms of revenue and is anticipated to witness a CAGR of 4.7% from 2017 to 2025 owing to high penetration of plastics in the manufacturing of bottles
- The generic drug segment accounted for 69.8% of the market in 2016 due to rapidly increasing manufacturing volumes of generic drugs in emerging economies
- Europe is expected to witness considerable growth during the forecast period owing to constant development in the medical field aimed at improving health and quality of life
- Some of the key companies present in the market are Corning Incorporated; Gerresheimer AG; Nipro Pharmapackaging; SCHOTT AG; ?i?ecam Group; Arab Pharmaceutical Glass Co.; Beatson Clark; Stevanato Group; and Owens-Illinois, Inc.
- Hemoglobinopathies Market - The global hemoglobinopathies market size was valued at USD 4.2 billion in 2014.
- Inhalation Anesthesia Market - The Global inhalation anesthesia market size was valued at USD 1.2 billion in 2014.
- Liposomal Doxorubicin Market - The global liposomal doxorubicin market size was valued at USD 814.6 million in 2015
- Biotechnology Reagents Market - Biotechnology reagent market depends on the growth of biotechnology instrumentation market.
- Pharmaceutical Glass Packaging Product Outlook (Revenue, USD Million, 2014 - 2025)
- Vials
- Small vials (<30ml)
- Large vials (>30ml)
- Bottles
- Small Bottles (< 1000 ml)
- Large Bottles (> 1000 ml)
- Cartridges & Syringes
- Ampoules
- Vials
- Pharmaceutical Glass Packaging Drug Type Outlook (Revenue, USD Million, 2014 - 2025)
- Generic
- Branded
- Biologic
- Pharmaceutical Glass Packaging Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Asia Pacific
- China
- India
- Japan
- South Korea
- Central & South America
- Brazil
- Middle East & Africa
- North America
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
Web: https://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
